Nanobody-based RFP-dependent Cre recombinase for selective anterograde tracing in RFP-expressing transgenic animals.
Ayumu InutsukaSho MaejimaHiroyuki MizoguchiRyosuke KanekoRei NomuraKeiko TakanamiHirotaka SakamotoTatsushi OnakaPublished in: Communications biology (2022)
Transgenic animals expressing fluorescent proteins are widely used to label specific cells and proteins. By using a split Cre recombinase fused with mCherry-binding nanobodies or designed ankyrin repeat proteins, we created Cre recombinase dependent on red fluorescent protein (RFP) (Cre-DOR). Functional binding units for monomeric RFPs are different from those for polymeric RFPs. We confirmed selective target RFP-dependent gene expression in the mouse cerebral cortex using stereotaxic injection of adeno-associated virus vectors. In estrogen receptor-beta (Esr2)-mRFP1 mice and gastrin-releasing peptide receptor (Grpr)-mRFP1 rats, we confirmed that Cre-DOR can be used for selective tracing of the neural projection from RFP-expressing specific neurons. Cellular localization of RFPs affects recombination efficiency of Cre-DOR, and light and chemical-induced nuclear translocation of an RFP-fused protein can modulate Cre-DOR efficiency. Our results provide a method for manipulating gene expression in specific cells expressing RFPs and expand the repertory of nanobody-based genetic tools.
Keyphrases
- gene expression
- estrogen receptor
- induced apoptosis
- dna methylation
- cell cycle arrest
- binding protein
- quantum dots
- spinal cord
- oxidative stress
- protein protein
- subarachnoid hemorrhage
- dna damage
- wild type
- type diabetes
- genome wide
- computed tomography
- spinal cord injury
- small molecule
- label free
- brain injury
- blood brain barrier
- stress induced
- image quality